Full-dose heparin anticoagulation as prevention for COVID-19 disease progression in non-critically ill patients: An up-to-date brief meta-analysis.

Full-dose heparin anticoagulation as prevention for COVID-19 disease progression in non-critically ill patients: An up-to-date brief meta-analysis.

Publication date: Dec 20, 2025

Concepts Keywords
Anticoagulation Anticoagulant
Covid COVID-19
Date Heparin
Thrombolysis LMWH
SARS-CoV-2

Semantics

Type Source Name
drug DRUGBANK Heparin
disease MESH COVID-19
disease MESH disease progression
disease MESH critically ill

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *